Naoki Shijubou
8PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 19, 2026
Six-Month Benralizumab Maintenance for Relapsing Chronic Eosinophilic Pneumonia Guided by Eosinophil Kinetics.Toshiyuki Sumi, Taiki Ishigooka, Kazuya Takeda
|Jun 03, 2024
Risk factors for severe immune-related pneumonitis after nivolumab plus ipilimumab therapy for non-small cell lung cancer.Toshiyuki Sumi, Motoki Sekikawa, Yuta Koshino
|Mar 14, 2024
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors.Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo
|Apr 10, 2022
Immunological and nutritional predictive factors in patients receiving pembrolizumab for the first-line treatment of non-small cell lung cancer.Naoki Shijubou, Toshiyuki Sumi, Yuichi Yamada
|Jul 17, 2021
Pseudocirrhosis due to liver metastasis from lung adenocarcinoma.Naoki Shijubou, Toshiyuki Sumi, Yoshiko Keira
|May 12, 2021
Long-term response to osimertinib in elderly patients with lung adenocarcinoma harbouring de novo EGFR T790M: a case report and literature review.Toshiyuki Sumi, Koki Kamada, Naoki Shijubou
Pageof 2
